Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
27 pharmaceutical companies were listed in the "2018 Guangdong Top 500 Enterprises in terms of Competitiveness"
Published Time：
2019-01-16
Seven pharmaceutical companies ranked among the top 100 in the overall list: Guangzhou Pharmaceutical Holdings Limited, Sinopharm Zhijun Pharmaceutical Co., Ltd., Shenzhen Haiwang Group Co., Ltd., Kangmei Pharmaceutical Co., Ltd., Shenzhen Haiwang Bio-engineering Co., Ltd., Joincare Pharmaceutical Group Industry Co., Ltd., and Lizhu Pharmaceutical Group Co., Ltd.
Guangzhou Pharmaceutical Holdings Limited Ranking: 25
Guangzhou Pharmaceutical Holdings Limited is one of the largest traditional Chinese medicine manufacturers in China. For Guangzhou Pharmaceutical Holdings Limited, traditional Chinese medicine is a strength and an industry characteristic. The "fashionable traditional Chinese medicine" strategy directly drives the development of Guangzhou Pharmaceutical Holdings Limited. Currently, market competition in the health industry is becoming more intense, and the era of industry transformation has arrived. Chairman Li Chuyuan said that Guangzhou Pharmaceutical Holdings Limited must seize the opportunities of the new round of reform and opening up, strive to be a leader, build a world-class enterprise with unique industrial characteristics and distinctive culture, and strive to enter the world's top 500 by 2020.
Sinopharm Zhijun Pharmaceutical Co., Ltd. Ranking: 41
Sinopharm Zhijun Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical listed company integrating pharmaceutical R&D, pharmaceutical manufacturing, pharmaceutical distribution, and pharmaceutical logistics. It undertakes the task of national, provincial, and municipal government pharmaceutical reserves. Sinopharm Zhijun's pharmaceutical distribution business ranks among the top in Guangdong and Guangxi provinces, ranking among the top 20 in China's pharmaceutical commerce. Its subsidiaries are located in Shenzhen, Guangzhou, Dongguan, Foshan, Zhanjiang, Meizhou, Zhaoqing, Huizhou, Nanning, Liuzhou, Jiangmen, Guilin, Yulin, Baise and other regions, with businesses covering hospital pure sales, commercial transfer, pharmaceutical express delivery and terminal distribution and other business formats.
Shenzhen Haiwang Group Co., Ltd. Ranking: 50
Haiwang Group is a large comprehensive pharmaceutical group company committed to pharmaceutical manufacturing, commercial circulation and retail chains. For many years, Haiwang has always adhered to the pharmaceutical industry as its core, and taken the revitalization of the national pharmaceutical industry as its responsibility. The operating scale has continuously expanded, and has formed three pillar industrial systems: pharmaceutical industrial manufacturing, pharmaceutical retail chains, and pharmaceutical commercial circulation.
Kangmei Pharmaceutical Co., Ltd. Ranking: 55
Kangmei Pharmaceutical is a large modern pharmaceutical enterprise and a national key high-tech enterprise, mainly engaged in the production of traditional Chinese medicine slices, chemical raw materials and preparations, and integrating drug production, R&D, and marketing of drugs and medical devices. Recently, Kangmei Pharmaceutical encountered a Waterloo. At the beginning of 2019, Kangmei Pharmaceutical's stock price continuously hit the limit down, and its market value evaporated more than 100 billion yuan from its highest point. The future of Kangmei Pharmaceutical remains shrouded in mystery.
Shenzhen Haiwang Bio-engineering Co., Ltd. Ranking: 64
Shenzhen Haiwang Bio-engineering Co., Ltd. is a large comprehensive enterprise group integrating pharmaceutical product R&D, pharmaceutical industrial manufacturing, pharmaceutical commercial circulation, and pharmaceutical retail chains. Haiwang Group's pharmaceutical product R&D, pharmaceutical industrial manufacturing, and pharmaceutical commercial circulation are the businesses of Haiwang Bio-engineering Co., Ltd., which was listed in 1998. For many years, the company has been committed to the forefront of the biopharmaceutical industry, actively promoting technological innovation, and continuously developing in the pharmaceutical and bioengineering industries, achieving rapid development.
Joincare Pharmaceutical Group Industry Co., Ltd. Ranking: 89
Recently, Joincare Pharmaceutical Group Industry Co., Ltd.'s wholly-owned subsidiary, Shenzhen Taita Pharmaceutical Co., Ltd., won the 20th China Patent Excellence Award for its invention patent "A Traditional Chinese Medicine Preparation for the Treatment of Women's Menopausal Syndrome" (Patent No.: ZL01139059.X). The award fully demonstrates the company's independent R&D and technological innovation capabilities, and also represents the company's high level of technological technology and intellectual property protection awareness. The company will continue to increase R&D investment and continuously enhance the market competitiveness of its products.
Lizhu Pharmaceutical Group Co., Ltd. Ranking: 90
As an important member of the pharmaceutical industry, judging from the current product structure, Lizhu Pharmaceutical Group Co., Ltd. still occupies a place in the huge pharmaceutical market. For example, the company's digestive drugs have huge growth potential, and microsphere drugs also have growth potential. Although Lizhu Pharmaceutical's stock price has been halved in the past 10 months, with the largest drop reaching 62.3%, which is a relatively large drop in the pharmaceutical industry, it is believed that the company can also actively take measures to solve the development problems.
Article link: China Pharmaceutical Network http://www.zyzhan.com/news/detail/73131.html
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.